Senior Advisory Panel

Addressing the full range of biological risks requires an extensive variety of expertise. For this purpose, the ICLS created a Senior Advisory Panel (SAP) as an additional resource. SAP members come from private industry, universities, non-profits and governments, and represent several geographic areas. 

Dr.   Abdallah  Daar Professor of Public Health Sciences, University of Toronto Co-director, McLaughlin-Rotman Centre Program on Life Sciences and Global Health Director of Ethics and Policy at the McLaughlin Centre for Molecular Medicine

Robert  Erwin Chairman, Novici Biotech President, Integrated Biopharma

Dr.   Paul  Fischer President and Chief Executive Officer, GenVec

Dr.   William  Haseltine President, Haseltine Associates

Dr.   Sanders  Martin L. Deputy Director, Office of Health and Safety, Centers for Disease Control and Prevention

Dr.   Erling  Myhre University Hospital Lund

Dr.   Anwar  Nasim Organization of Islamic Conference Standing Committee on Scientific and Technological Cooperation (COMSTECH) Higher Education Commission of Pakistan Patron, Pakistan Biological Safety Association

Dr.   Mikhail  Paltsev Rector, Moscow Medical Academy Chairman, Scientific and Technical Council, TEMPO Co-Chairman, International Advisory Group

Dr.   Charles  Penn Founder and Chief Development Officer, Syntaxin Former R&D Director, UK Health Protection Agency

Professor   Dame Julia  Polak Emeritus Professor, Imperial College Former Director, Tissue Engineering and Regenerative Medicine Centre, Imperial College

Dr.   George  Poste Director, Biodesign Institute at Arizona State University Non-executive Chairman and Chief Scientific Adviser, CDX Holdings

Dr.   Una  Ryan President and Chief Executive Officer, Waltham Technologies

Dr.   Gurinder  Shahi BioEnterprise Asia

Dr.   Mark  Smolinski Director, Predict and Prevent Initiative, Google.org

Dr.   Rainer  Wessel President and Chief Executive Officer, GANYMED Pharmaceuticals AG